SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Luthman, J.
Right arrow Articles by Archer, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Luthman, J.
Right arrow Articles by Archer, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ketanserin and mianserin treatment reverses hyperactivity in neonatally dopamine-lesioned rats

J. Luthman

Department of Histology and Neurobiology, Karolinska Institutet, Stockholm, Sweden, Departments of Pharmacology and Psychiatry, University of Colorado Health Sciences Center, Denver, USA

A. Fredriksson

Neurophysiology Laboratory, Psychiatric Research Center, Uller-kers Hospital, Uppsala, Sweden

A. Plaznik

Neurophysiology Laboratory, Psychiatric Research Center, Uller-kers Hospital, Uppsala, Sweden

T. Archer

Department of Psychology, University of Gothenburg, Gothenburg, Sweden

Selective brain dopamine (DA) depletions in rats, induced by neonatal intracisternal administration of 6-hydroxydopamine (6-OHDA; 75 µg), caused spontaneous hyperactivity at the adult stage as measured using determinations of locomotion, rearing and total activity. Treatment with ketanserin (0.5 or 1.0 mg/kg, s.c.) reversed the hyperactivity in 6-OHDA-treated animals during a 90-min period following injection, although only the low dose of ketanserin reduced rearings. In control animals ketanserin treatment did not affect the locomotion or total activity counts, while the high dose of ketanserin increased rearings. Following treatment with mianserin (0.5 or 1.0 mg/kg, s.c.), a similar effect was seen; however, it was longer-lasting and mianserin treatment increased activity in controls. Regional analysis of monoamine levels demonstrated a marked reduction of basal forebrain DA levels, while in striatum an increase in serotonin (5-HT) concentration was seen following the 6-OHDA treatment. The results indicate that drugs with a high affinity to 5-HT2 binding sites can influence the hyperactivity seen in neonatally DA-lesioned rats. This effect might be related to inhibition of 5-HT pathways directly involved in regulation of motor activity or due to alterations in the interaction between the DA and 5-HT systems as a consequence of the early DA lesion.

Journal of Psychopharmacology, Vol. 5, No. 4, 418-425 (1991)
DOI: 10.1177/026988119100500437


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. Bishop, J. L. Tessmer, T. Ullrich, K. C. Rice, and P. D. Walker
Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A/2C Agonism
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 687 - 694.
[Abstract] [Full Text] [PDF]



Advertisement